-
EP4108670
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4108670
| EP4108670 - BRIDGED NUCLEOSIDE AND NUCLEOTIDE USING SAME [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 25.11.2022 Database last updated on 03.09.2024 | |
| Former | The international publication has been made Status updated on 27.08.2021 | Most recent event Tooltip | 16.03.2024 | Supplementary search report | published on 17.04.2024 [2024/16] | Applicant(s) | For all designated states OSAKA UNIVERSITY 1-1, Yamadaoka Suita-shi Osaka 565-0871 / JP | For all designated states Japan As Represented By Director General Of National Institute Of Health Sciences 3-25-26 Tonomachi, Kawasaki-ku Kawasaki-shi, Kanagawa, 210-0821 / JP | [2022/52] | Inventor(s) | 01 /
OBIKA, Satoshi c/o OSAKA UNIVERSITY, 1-1, Yamadaoka Suita-shi, Osaka 565-0871 / JP | 02 /
YAMAGUCHI, Takao c/o OSAKA UNIVERSITY, 1-1, Yamadaoka Suita-shi, Osaka 565-0871 / JP | 03 /
KOMINE, Hibiki c/o OSAKA UNIVERSITY, 1-1, Yamadaoka Suita-shi, Osaka 565-0871 / JP | 04 /
SUGIURA, Takaya c/o OSAKA UNIVERSITY, 1-1, Yamadaoka Suita-shi, Osaka 565-0871 / JP | 05 /
INOUE, Takao c/o National Institute of Health Sciences, 25-26 Tonomachi 3-chome, Kawasaki-ku Kawasaki-shi, Kanagawa 210-9501 / JP | 06 /
YOSHIDA, Tokuyuki c/o National Institute of Health Sciences, 25-26 Tonomachi 3-chome, Kawasaki-ku Kawasaki-shi, Kanagawa 210-9501 / JP | [2022/52] | Representative(s) | Boynton, Juliette Alice, et al Schlich 9 St. Catherine's Road Littlehampton, West Sussex BN17 5HS / GB | [2022/52] | Application number, filing date | 21756952.4 | 18.02.2021 | [2022/52] | WO2021JP06222 | Priority number, date | JP20200026646 | 19.02.2020 Original published format: JP 2020026646 | [2022/52] | Filing language | JA | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021167029 | Date: | 26.08.2021 | Language: | JA | [2021/34] | Type: | A1 Application with search report | No.: | EP4108670 | Date: | 28.12.2022 | Language: | EN | [2022/52] | Search report(s) | International search report - published on: | JP | 26.08.2021 | (Supplementary) European search report - dispatched on: | EP | 15.03.2024 | Classification | IPC: | C07H19/06, C07H19/16, C07H21/00, C07H1/00, C12N15/09 | [2024/16] | CPC: |
C07H19/06 (EP);
C07H21/02 (US);
C07H1/00 (EP);
C07H19/16 (EP);
C07H21/00 (EP);
C12N15/113 (EP);
C12N2310/11 (EP);
C12N2310/315 (EP);
C12N2310/3231 (EP);
Y02P20/55 (EP)
(-)
|
| Former IPC [2022/52] | C07H19/06, C07H21/00, C12N15/09 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/52] | Title | German: | VERBRÜCKTES NUKLEOSID UND DIESES VERWENDENDES NUKLEOTID | [2022/52] | English: | BRIDGED NUCLEOSIDE AND NUCLEOTIDE USING SAME | [2022/52] | French: | NUCLÉOSIDE PONTÉ ET NUCLÉOTIDE L'UTILISANT | [2022/52] | Entry into regional phase | 01.09.2022 | Translation filed | 01.09.2022 | National basic fee paid | 01.09.2022 | Search fee paid | 01.09.2022 | Designation fee(s) paid | 01.09.2022 | Examination fee paid | Examination procedure | 01.09.2022 | Examination requested [2022/52] | Fees paid | Renewal fee | 01.09.2022 | Renewal fee patent year 03 | 14.02.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]WO2009006478 (ISIS PHARMACEUTICALS INC [US], et al); | [YD]EP3109254 (UNIV OSAKA [JP]); | [Y]EP3415524 (UNIV OSAKA [JP], et al); | International search | [A]WO2009006478 (ISIS PHARMACEUTICALS INC [US], et al)[A] 1-9; | [XY]WO2015125783 (UNIV OSAKA [JP]) [X] 1-9 * [0011]-[0023], [0047]-[0059], 1-1 0 * [Y] 1-9; | [A]WO2017119463 (UNIV OSAKA [JP], et al) [A] 1-9; | [Y]WO2018155451 (UNIV OSAKA [JP]) [Y] 1-9 * [00 14] - [0 0 34], [0 0 57], [0 0 58], [0069] ~ [0099] *; | [A]WO2019009298 (UNIV OSAKA [JP], et al) [A] 1-9; | [A]WO2020027227 (UNIV OSAKA [JP], et al) [A] 1-9 | by applicant | WO2015125783 | - S. OBIKA et al., T. Tetrahedron Lett., (19970000), vol. 38, pages 8735 - 8738 | - S. SINGH et al., J. Chem. Commun., (19980000), pages 455 - 456 | - E. SWAYZE et al., Nucleic Acids Res., (20070000), vol. 35, pages 687 - 700 | - P.P. SETH et al., J. Org. Chem., (20100000), vol. 75, pages 1569 - 1581 | - YAMAGUCHI, T. et al., Chem. Commun., (20150000), vol. 51, no. 51, pages 9737 - 9740 | - M. KUWAHARA et al., Nucleic Acids Res., (20080000), vol. 36, no. 13, pages 4257 - 4265 |